TGFB1 and melanoma: Knockdown of Smad4, inhibition of Smad7 expression, and expression of a dominant-negative TGFBR2 can all block the TGF-β signaling pathway and significantly reduce bone metastasis in breast and melanoma models, further giving evidence of that the TGF-β signaling pathway participate in bone metastasis28.